274 related articles for article (PubMed ID: 11215087)
1. IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.
Cohen J;
AIDS Read; 2001 Jan; 11(1):41-2. PubMed ID: 11215087
[TBL] [Abstract][Full Text] [Related]
2. HIV clinical trials in correctional settings: right or retrogression?
De Groot AS; Bick J; Thomas D; Stubblefield E
AIDS Read; 2001 Jan; 11(1):34-40. PubMed ID: 11215086
[TBL] [Abstract][Full Text] [Related]
3. Research infrastructure and IRB/FDA requirements.
Cohen J
Med Health R I; 2000 Dec; 83(12):382-5. PubMed ID: 11190124
[No Abstract] [Full Text] [Related]
4. On research on HIV infection and AIDS in correctional institutions.
Dubler NN; Sidel VW
Milbank Q; 1989; 67(2):171-207. PubMed ID: 2630900
[TBL] [Abstract][Full Text] [Related]
5. FDA evaluates accelerated approval process. Food and Drug Administration.
Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
[TBL] [Abstract][Full Text] [Related]
6. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
7. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
[TBL] [Abstract][Full Text] [Related]
8. Beneficial and unusual punishment: an argument in support of prisoner participation in clinical trials.
Hoffman S
Indiana Law Rev; 2000; 33(2):475-515. PubMed ID: 16189915
[No Abstract] [Full Text] [Related]
9. HIV/AIDS behind bars.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1998 Apr; 4(4):8-13. PubMed ID: 11365184
[TBL] [Abstract][Full Text] [Related]
10. Human subject protection in clinical trials.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):19-23. PubMed ID: 11363958
[TBL] [Abstract][Full Text] [Related]
11. A qualitative exploration of HIV/AIDS health care services in Indian prisons.
Guin S
J Correct Health Care; 2009 Jul; 15(3):179-89. PubMed ID: 19477802
[TBL] [Abstract][Full Text] [Related]
12. Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(17 pt 2):8958-79. PubMed ID: 10249529
[TBL] [Abstract][Full Text] [Related]
13. HIV-infected prisoners: what mental health services are constitutionally mandated?
Mayer C
J Psychiatry Law; 1995; 23(4):517-53. PubMed ID: 12199277
[TBL] [Abstract][Full Text] [Related]
14. Editorial: time to end the death trials.
James JS
AIDS Treat News; 1996 Aug; (no 252):1-4. PubMed ID: 11363751
[TBL] [Abstract][Full Text] [Related]
15. FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Aug; (no 228):5-6. PubMed ID: 11362627
[TBL] [Abstract][Full Text] [Related]
16. Recruiting human subjects without IRB review/approval.
Maloney DM
Hum Res Rep; 2002 Aug; 17(8):3. PubMed ID: 12731493
[No Abstract] [Full Text] [Related]
17. U.S. prisoners' access to experimental HIV therapies.
Collins A; Baumgartner D; Henry K
Minn Med; 1995 Nov; 78(11):45-8. PubMed ID: 8531905
[TBL] [Abstract][Full Text] [Related]
18. Protection of human subjects; informed consent--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(17 pt 2):8942-58. PubMed ID: 10249528
[TBL] [Abstract][Full Text] [Related]
19. Symptom-reduction trials at FDA clinical trials workshop. Food and Drug Administration.
James JS
AIDS Treat News; 1995 Sep; (no 231):7. PubMed ID: 11362873
[TBL] [Abstract][Full Text] [Related]
20. Human subject protections in the United States: perspectives from the Office for Protection from Research Risks.
Russell-Einhorn M; Ellis GB
J Biolaw Bus; 1998; 1(2):36-8. PubMed ID: 12739540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
